Copyright
©The Author(s) 2023.
World J Hepatol. Mar 27, 2023; 15(3): 419-430
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Published online Mar 27, 2023. doi: 10.4254/wjh.v15.i3.419
Parameter | Pre-clinical decision support tool (n = 115) | Post-clinical decision support tool (n = 843) | P value |
Physician ordering FibroScan (%) | < 0.0001 | ||
Primary care | 33 | 67.1 | |
Specialty care | 67 | 32.9 | |
Exam probe used (%) | 0.9453 | ||
Medium | 44.3 | 44 | |
Extra large (XL) | 55.7 | 56 | |
FibroScan result (%) | |||
Fibrosis score | 0.0142 | ||
F0 | 32.2 | 38.1 | |
F1 | 7.8 | 14.2 | |
F2 | 17.4 | 17.9 | |
F3 | 13.9 | 13.3 | |
F4 | 28.7 | 16.5 | |
Steatosis score | < 0.0001 | ||
S0 | 43.5 | 8.1 | |
S1 | 4.3 | 10 | |
S2 | 8.7 | 14.7 | |
S3 | 43.5 | 67.3 |
- Citation: Stein L, Mittal R, Song H, Chung J, Sahota A. To scan or not to scan: Use of transient elastography in an integrated health system. World J Hepatol 2023; 15(3): 419-430
- URL: https://www.wjgnet.com/1948-5182/full/v15/i3/419.htm
- DOI: https://dx.doi.org/10.4254/wjh.v15.i3.419